Machine-learning approaches in drug discovery: methods and applications.

Area of Science:

• Cheminformatics
• Computational Chemistry
• Machine Learning in Drug Discovery

Background:

• Virtual screening (VS) has advanced from single-compound similarity searches to complex data mining and machine learning.
• The availability of large public chemical and biological datasets fuels the development of novel learning methodologies.

Purpose of the Study:

• To review machine learning techniques in ligand-based virtual screening (LBVS).
• To analyze recent VS studies, detailing the current state-of-the-art.
• To highlight challenges, successes, and future directions in LBVS.

Main Methods:

• Focus on machine learning approaches within ligand-based virtual screening.
• Analysis of recent publications and case studies in VS.
• Review of data mining techniques applied to chemical and biological data.

Main Results:

• Machine learning requires large, representative training sets for robust decision rules in VS.
• Significant progress has been made in applying ML to LBVS.
• Several challenges and opportunities for future advancements have been identified.

Conclusions:

• Ligand-based virtual screening has significantly benefited from machine learning integration.
• Further research is needed to address current limitations and capitalize on opportunities in LBVS.
• The field shows great promise for accelerating drug discovery and development.